nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP3A4—prostate cancer	0.105	1	CbGaD
Ketamine—CYP2C8—Nilutamide—prostate cancer	0.0392	0.0672	CbGbCtD
Ketamine—CYP2C8—Abiraterone—prostate cancer	0.0325	0.0557	CbGbCtD
Ketamine—CYP2B6—Estrone—prostate cancer	0.031	0.0532	CbGbCtD
Ketamine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0303	0.0519	CbGbCtD
Ketamine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0277	0.0474	CbGbCtD
Ketamine—CYP2C9—Nilutamide—prostate cancer	0.0274	0.0469	CbGbCtD
Ketamine—CYP2C9—Bicalutamide—prostate cancer	0.0274	0.0469	CbGbCtD
Ketamine—ABCB1—Estramustine—prostate cancer	0.0247	0.0423	CbGbCtD
Ketamine—CYP2C8—Cabazitaxel—prostate cancer	0.024	0.0412	CbGbCtD
Ketamine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0209	0.0359	CbGbCtD
Ketamine—CYP2C9—Estrone—prostate cancer	0.0164	0.0281	CbGbCtD
Ketamine—ABCB1—Cabazitaxel—prostate cancer	0.0163	0.0279	CbGbCtD
Ketamine—CYP3A4—Bicalutamide—prostate cancer	0.0159	0.0273	CbGbCtD
Ketamine—ABCB1—Estrone—prostate cancer	0.0159	0.0273	CbGbCtD
Ketamine—PTGS1—Etoposide—prostate cancer	0.0153	0.0262	CbGbCtD
Ketamine—CYP3A4—Estramustine—prostate cancer	0.0148	0.0253	CbGbCtD
Ketamine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0142	0.0243	CbGbCtD
Ketamine—CYP2C8—Estradiol—prostate cancer	0.0135	0.0231	CbGbCtD
Ketamine—CYP3A4—Flutamide—prostate cancer	0.0132	0.0226	CbGbCtD
Ketamine—CYP3A4—Abiraterone—prostate cancer	0.0132	0.0226	CbGbCtD
Ketamine—CYP2C9—Capecitabine—prostate cancer	0.0124	0.0213	CbGbCtD
Ketamine—ABCB1—Conjugated Estrogens—prostate cancer	0.0104	0.0178	CbGbCtD
Ketamine—CYP3A4—Cabazitaxel—prostate cancer	0.00975	0.0167	CbGbCtD
Ketamine—CYP3A4—Estrone—prostate cancer	0.00953	0.0163	CbGbCtD
Ketamine—ABCB1—Mitoxantrone—prostate cancer	0.00946	0.0162	CbGbCtD
Ketamine—CYP2C9—Estradiol—prostate cancer	0.00941	0.0161	CbGbCtD
Ketamine—ABCB1—Estradiol—prostate cancer	0.00914	0.0157	CbGbCtD
Ketamine—CYP2C8—Etoposide—prostate cancer	0.00881	0.0151	CbGbCtD
Ketamine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00849	0.0146	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—prostate cancer	0.00794	0.0136	CbGbCtD
Ketamine—ABCB1—Prednisone—prostate cancer	0.00786	0.0135	CbGbCtD
Ketamine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00623	0.0107	CbGbCtD
Ketamine—Epilepsy—Estrone—prostate cancer	0.00601	0.0527	CcSEcCtD
Ketamine—ABCB1—Etoposide—prostate cancer	0.00596	0.0102	CbGbCtD
Ketamine—CYP3A4—Mitoxantrone—prostate cancer	0.00567	0.00971	CbGbCtD
Ketamine—CYP3A4—Estradiol—prostate cancer	0.00547	0.00938	CbGbCtD
Ketamine—ABCB1—Docetaxel—prostate cancer	0.00546	0.00935	CbGbCtD
Ketamine—Epilepsy—Estradiol valerate/Dienogest—prostate cancer	0.00524	0.046	CcSEcCtD
Ketamine—CYP3A4—Prednisone—prostate cancer	0.00471	0.00806	CbGbCtD
Ketamine—ABCB1—Doxorubicin—prostate cancer	0.00407	0.00697	CbGbCtD
Ketamine—CYP3A4—Etoposide—prostate cancer	0.00357	0.00612	CbGbCtD
Ketamine—CYP3A4—Docetaxel—prostate cancer	0.00327	0.0056	CbGbCtD
Ketamine—GRIN2D—prostate gland—prostate cancer	0.0031	0.093	CbGeAlD
Ketamine—GRIN3B—testis—prostate cancer	0.00306	0.0917	CbGeAlD
Ketamine—Epilepsy—Conjugated Estrogens—prostate cancer	0.00278	0.0244	CcSEcCtD
Ketamine—TACR1—prostate gland—prostate cancer	0.00253	0.0758	CbGeAlD
Ketamine—CYP3A4—Doxorubicin—prostate cancer	0.00244	0.00418	CbGbCtD
Ketamine—Epilepsy—Estradiol—prostate cancer	0.00222	0.0195	CcSEcCtD
Ketamine—CYP2C9—urine—prostate cancer	0.00209	0.0625	CbGeAlD
Ketamine—Cystitis noninfective—Flutamide—prostate cancer	0.00206	0.0181	CcSEcCtD
Ketamine—Cystitis—Flutamide—prostate cancer	0.00204	0.0179	CcSEcCtD
Ketamine—OPRK1—prostate gland—prostate cancer	0.00197	0.059	CbGeAlD
Ketamine—Bladder pain—Flutamide—prostate cancer	0.00191	0.0168	CcSEcCtD
Ketamine—Cystitis noninfective—Cabazitaxel—prostate cancer	0.00174	0.0153	CcSEcCtD
Ketamine—TACR1—renal system—prostate cancer	0.00173	0.0517	CbGeAlD
Ketamine—Cystitis—Cabazitaxel—prostate cancer	0.00172	0.0151	CcSEcCtD
Ketamine—Bladder pain—Cabazitaxel—prostate cancer	0.00161	0.0142	CcSEcCtD
Ketamine—CYP3A4—urine—prostate cancer	0.00159	0.0477	CbGeAlD
Ketamine—GRIN2C—testis—prostate cancer	0.00147	0.0441	CbGeAlD
Ketamine—OPRD1—renal system—prostate cancer	0.0014	0.042	CbGeAlD
Ketamine—GRIN2D—testis—prostate cancer	0.00137	0.041	CbGeAlD
Ketamine—GRIN3A—testis—prostate cancer	0.00129	0.0385	CbGeAlD
Ketamine—Cystitis noninfective—Ethinyl Estradiol—prostate cancer	0.00126	0.0111	CcSEcCtD
Ketamine—Cystitis—Ethinyl Estradiol—prostate cancer	0.00125	0.011	CcSEcCtD
Ketamine—Epilepsy—Prednisone—prostate cancer	0.00123	0.0108	CcSEcCtD
Ketamine—Bladder pain—Ethinyl Estradiol—prostate cancer	0.00117	0.0103	CcSEcCtD
Ketamine—TACR1—testis—prostate cancer	0.00112	0.0334	CbGeAlD
Ketamine—Arrhythmia—Abiraterone—prostate cancer	0.00104	0.00914	CcSEcCtD
Ketamine—Cystitis noninfective—Goserelin—prostate cancer	0.00104	0.00913	CcSEcCtD
Ketamine—Cystitis noninfective—Conjugated Estrogens—prostate cancer	0.00103	0.00905	CcSEcCtD
Ketamine—Cystitis—Goserelin—prostate cancer	0.00103	0.00903	CcSEcCtD
Ketamine—Cystitis—Conjugated Estrogens—prostate cancer	0.00102	0.00894	CcSEcCtD
Ketamine—GRIN2A—testis—prostate cancer	0.00102	0.0304	CbGeAlD
Ketamine—Bladder pain—Goserelin—prostate cancer	0.000963	0.00845	CcSEcCtD
Ketamine—Bladder pain—Conjugated Estrogens—prostate cancer	0.000954	0.00837	CcSEcCtD
Ketamine—Erythema—Flutamide—prostate cancer	0.000923	0.0081	CcSEcCtD
Ketamine—Laryngospasm—Etoposide—prostate cancer	0.000877	0.0077	CcSEcCtD
Ketamine—Arrhythmia—Degarelix—prostate cancer	0.00085	0.00746	CcSEcCtD
Ketamine—Erythema—Degarelix—prostate cancer	0.000828	0.00727	CcSEcCtD
Ketamine—Cystitis noninfective—Estradiol—prostate cancer	0.000825	0.00724	CcSEcCtD
Ketamine—Cystitis—Estradiol—prostate cancer	0.000815	0.00716	CcSEcCtD
Ketamine—Anaphylactic shock—Estrone—prostate cancer	0.000815	0.00715	CcSEcCtD
Ketamine—Anorexia—Estramustine—prostate cancer	0.000813	0.00714	CcSEcCtD
Ketamine—TACR1—lymph node—prostate cancer	0.000808	0.0242	CbGeAlD
Ketamine—Arrhythmia—Cabazitaxel—prostate cancer	0.000801	0.00703	CcSEcCtD
Ketamine—Bradycardia—Bicalutamide—prostate cancer	0.000783	0.00687	CcSEcCtD
Ketamine—Vision blurred—Degarelix—prostate cancer	0.000781	0.00685	CcSEcCtD
Ketamine—Erythema—Cabazitaxel—prostate cancer	0.00078	0.00685	CcSEcCtD
Ketamine—Apnoea—Etoposide—prostate cancer	0.000772	0.00678	CcSEcCtD
Ketamine—Bladder pain—Estradiol—prostate cancer	0.000763	0.0067	CcSEcCtD
Ketamine—Shock—Nilutamide—prostate cancer	0.000744	0.00654	CcSEcCtD
Ketamine—Decreased appetite—Estramustine—prostate cancer	0.000741	0.00651	CcSEcCtD
Ketamine—Anorexia—Nilutamide—prostate cancer	0.000721	0.00633	CcSEcCtD
Ketamine—Anorexia—Flutamide—prostate cancer	0.000718	0.0063	CcSEcCtD
Ketamine—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000711	0.00624	CcSEcCtD
Ketamine—Pain—Estrone—prostate cancer	0.000697	0.00612	CcSEcCtD
Ketamine—Arrhythmia—Bicalutamide—prostate cancer	0.000687	0.00603	CcSEcCtD
Ketamine—PTGS1—prostate gland—prostate cancer	0.000684	0.0205	CbGeAlD
Ketamine—Anaphylactic shock—Degarelix—prostate cancer	0.000676	0.00593	CcSEcCtD
Ketamine—Decreased appetite—Nilutamide—prostate cancer	0.000658	0.00577	CcSEcCtD
Ketamine—Decreased appetite—Flutamide—prostate cancer	0.000655	0.00575	CcSEcCtD
Ketamine—Pain—Nilutamide—prostate cancer	0.000647	0.00568	CcSEcCtD
Ketamine—Hypotension—Degarelix—prostate cancer	0.000632	0.00555	CcSEcCtD
Ketamine—OPRM1—testis—prostate cancer	0.000618	0.0185	CbGeAlD
Ketamine—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000608	0.00534	CcSEcCtD
Ketamine—Anorexia—Cabazitaxel—prostate cancer	0.000607	0.00533	CcSEcCtD
Ketamine—Hypotension—Cabazitaxel—prostate cancer	0.000595	0.00522	CcSEcCtD
Ketamine—Decreased appetite—Degarelix—prostate cancer	0.000588	0.00516	CcSEcCtD
Ketamine—PTGS1—seminal vesicle—prostate cancer	0.000579	0.0173	CbGeAlD
Ketamine—Pain—Degarelix—prostate cancer	0.000578	0.00507	CcSEcCtD
Ketamine—CYP2C8—renal system—prostate cancer	0.000575	0.0172	CbGeAlD
Ketamine—Decreased appetite—Cabazitaxel—prostate cancer	0.000554	0.00486	CcSEcCtD
Ketamine—Pain—Cabazitaxel—prostate cancer	0.000545	0.00478	CcSEcCtD
Ketamine—Vomiting—Estramustine—prostate cancer	0.000542	0.00476	CcSEcCtD
Ketamine—Rash—Estramustine—prostate cancer	0.000538	0.00472	CcSEcCtD
Ketamine—Shock—Bicalutamide—prostate cancer	0.000537	0.00472	CcSEcCtD
Ketamine—Dermatitis—Estramustine—prostate cancer	0.000537	0.00472	CcSEcCtD
Ketamine—Vomiting—Abiraterone—prostate cancer	0.000527	0.00462	CcSEcCtD
Ketamine—Rash—Abiraterone—prostate cancer	0.000522	0.00458	CcSEcCtD
Ketamine—Dermatitis—Abiraterone—prostate cancer	0.000522	0.00458	CcSEcCtD
Ketamine—Anorexia—Bicalutamide—prostate cancer	0.000521	0.00457	CcSEcCtD
Ketamine—Vomiting—Estrone—prostate cancer	0.000518	0.00455	CcSEcCtD
Ketamine—CYP2B6—renal system—prostate cancer	0.000516	0.0154	CbGeAlD
Ketamine—Rash—Estrone—prostate cancer	0.000514	0.00451	CcSEcCtD
Ketamine—Nystagmus—Epirubicin—prostate cancer	0.000514	0.00451	CcSEcCtD
Ketamine—Dermatitis—Estrone—prostate cancer	0.000513	0.00451	CcSEcCtD
Ketamine—Nausea—Estramustine—prostate cancer	0.000507	0.00445	CcSEcCtD
Ketamine—PTGS1—epithelium—prostate cancer	0.000503	0.0151	CbGeAlD
Ketamine—Nausea—Estrone—prostate cancer	0.000484	0.00425	CcSEcCtD
Ketamine—Vomiting—Nilutamide—prostate cancer	0.000481	0.00422	CcSEcCtD
Ketamine—Vomiting—Flutamide—prostate cancer	0.000479	0.00421	CcSEcCtD
Ketamine—Arrhythmia—Goserelin—prostate cancer	0.000478	0.00419	CcSEcCtD
Ketamine—Rash—Nilutamide—prostate cancer	0.000477	0.00419	CcSEcCtD
Ketamine—Dermatitis—Nilutamide—prostate cancer	0.000477	0.00418	CcSEcCtD
Ketamine—Nystagmus—Doxorubicin—prostate cancer	0.000475	0.00417	CcSEcCtD
Ketamine—Rash—Flutamide—prostate cancer	0.000475	0.00417	CcSEcCtD
Ketamine—Decreased appetite—Bicalutamide—prostate cancer	0.000475	0.00417	CcSEcCtD
Ketamine—Dermatitis—Flutamide—prostate cancer	0.000475	0.00417	CcSEcCtD
Ketamine—Arrhythmia—Conjugated Estrogens—prostate cancer	0.000473	0.00416	CcSEcCtD
Ketamine—Pain—Bicalutamide—prostate cancer	0.000467	0.0041	CcSEcCtD
Ketamine—PTGS1—renal system—prostate cancer	0.000466	0.014	CbGeAlD
Ketamine—Erythema—Goserelin—prostate cancer	0.000466	0.00409	CcSEcCtD
Ketamine—Erythema—Conjugated Estrogens—prostate cancer	0.000461	0.00405	CcSEcCtD
Ketamine—SLC6A2—testis—prostate cancer	0.000452	0.0135	CbGeAlD
Ketamine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000452	0.00397	CcSEcCtD
Ketamine—Nausea—Nilutamide—prostate cancer	0.000449	0.00395	CcSEcCtD
Ketamine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000448	0.00394	CcSEcCtD
Ketamine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000448	0.00393	CcSEcCtD
Ketamine—Nausea—Flutamide—prostate cancer	0.000447	0.00393	CcSEcCtD
Ketamine—Vision blurred—Goserelin—prostate cancer	0.000439	0.00385	CcSEcCtD
Ketamine—Vision blurred—Conjugated Estrogens—prostate cancer	0.000435	0.00382	CcSEcCtD
Ketamine—Vomiting—Degarelix—prostate cancer	0.00043	0.00377	CcSEcCtD
Ketamine—Rash—Degarelix—prostate cancer	0.000426	0.00374	CcSEcCtD
Ketamine—Dermatitis—Degarelix—prostate cancer	0.000426	0.00374	CcSEcCtD
Ketamine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000422	0.00371	CcSEcCtD
Ketamine—DRD2—testis—prostate cancer	0.000412	0.0123	CbGeAlD
Ketamine—Vomiting—Cabazitaxel—prostate cancer	0.000405	0.00355	CcSEcCtD
Ketamine—ABCB1—prostate gland—prostate cancer	0.000405	0.0121	CbGeAlD
Ketamine—Convulsion—Goserelin—prostate cancer	0.000403	0.00354	CcSEcCtD
Ketamine—Bradycardia—Mitoxantrone—prostate cancer	0.000402	0.00353	CcSEcCtD
Ketamine—Nausea—Degarelix—prostate cancer	0.000402	0.00353	CcSEcCtD
Ketamine—Convulsion—Conjugated Estrogens—prostate cancer	0.0004	0.00351	CcSEcCtD
Ketamine—CYP3A4—renal system—prostate cancer	0.00039	0.0117	CbGeAlD
Ketamine—Diplopia—Capecitabine—prostate cancer	0.000382	0.00336	CcSEcCtD
Ketamine—Anaphylactic shock—Goserelin—prostate cancer	0.00038	0.00334	CcSEcCtD
Ketamine—Nausea—Cabazitaxel—prostate cancer	0.000378	0.00332	CcSEcCtD
Ketamine—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000376	0.0033	CcSEcCtD
Ketamine—Shock—Goserelin—prostate cancer	0.000374	0.00328	CcSEcCtD
Ketamine—CYP2C8—testis—prostate cancer	0.000372	0.0111	CbGeAlD
Ketamine—Shock—Conjugated Estrogens—prostate cancer	0.00037	0.00325	CcSEcCtD
Ketamine—Erythema—Estradiol—prostate cancer	0.000369	0.00324	CcSEcCtD
Ketamine—Anorexia—Goserelin—prostate cancer	0.000362	0.00318	CcSEcCtD
Ketamine—Anorexia—Conjugated Estrogens—prostate cancer	0.000359	0.00315	CcSEcCtD
Ketamine—Cystitis noninfective—Epirubicin—prostate cancer	0.000358	0.00315	CcSEcCtD
Ketamine—Salivary hypersecretion—Epirubicin—prostate cancer	0.000356	0.00313	CcSEcCtD
Ketamine—Hypotension—Goserelin—prostate cancer	0.000355	0.00312	CcSEcCtD
Ketamine—Cystitis—Epirubicin—prostate cancer	0.000354	0.00311	CcSEcCtD
Ketamine—Arrhythmia—Mitoxantrone—prostate cancer	0.000353	0.0031	CcSEcCtD
Ketamine—Hypotension—Conjugated Estrogens—prostate cancer	0.000352	0.00309	CcSEcCtD
Ketamine—Vomiting—Bicalutamide—prostate cancer	0.000347	0.00305	CcSEcCtD
Ketamine—Rash—Bicalutamide—prostate cancer	0.000344	0.00302	CcSEcCtD
Ketamine—Dermatitis—Bicalutamide—prostate cancer	0.000344	0.00302	CcSEcCtD
Ketamine—Erythema—Mitoxantrone—prostate cancer	0.000344	0.00302	CcSEcCtD
Ketamine—ABCB1—seminal vesicle—prostate cancer	0.000342	0.0102	CbGeAlD
Ketamine—CYP2B6—testis—prostate cancer	0.000333	0.00998	CbGeAlD
Ketamine—Bladder pain—Epirubicin—prostate cancer	0.000332	0.00291	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—prostate cancer	0.000332	0.00291	CcSEcCtD
Ketamine—Decreased appetite—Goserelin—prostate cancer	0.00033	0.0029	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—prostate cancer	0.00033	0.00289	CcSEcCtD
Ketamine—SLC6A2—lymph node—prostate cancer	0.000328	0.00982	CbGeAlD
Ketamine—Cystitis—Doxorubicin—prostate cancer	0.000328	0.00288	CcSEcCtD
Ketamine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000327	0.00287	CcSEcCtD
Ketamine—Pain—Goserelin—prostate cancer	0.000325	0.00285	CcSEcCtD
Ketamine—Nausea—Bicalutamide—prostate cancer	0.000324	0.00285	CcSEcCtD
Ketamine—Vision blurred—Mitoxantrone—prostate cancer	0.000324	0.00285	CcSEcCtD
Ketamine—Pain—Conjugated Estrogens—prostate cancer	0.000322	0.00283	CcSEcCtD
Ketamine—Bladder pain—Doxorubicin—prostate cancer	0.000307	0.00269	CcSEcCtD
Ketamine—PTGS1—testis—prostate cancer	0.000301	0.00903	CbGeAlD
Ketamine—Anaphylactic shock—Estradiol—prostate cancer	0.000301	0.00264	CcSEcCtD
Ketamine—Convulsion—Mitoxantrone—prostate cancer	0.000298	0.00262	CcSEcCtD
Ketamine—ABCB1—epithelium—prostate cancer	0.000297	0.0089	CbGeAlD
Ketamine—Shock—Estradiol—prostate cancer	0.000296	0.0026	CcSEcCtD
Ketamine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000294	0.00258	CcSEcCtD
Ketamine—Rash—Ethinyl Estradiol—prostate cancer	0.000291	0.00256	CcSEcCtD
Ketamine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000291	0.00255	CcSEcCtD
Ketamine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000281	0.00246	CcSEcCtD
Ketamine—Shock—Mitoxantrone—prostate cancer	0.000276	0.00242	CcSEcCtD
Ketamine—ABCB1—renal system—prostate cancer	0.000276	0.00826	CbGeAlD
Ketamine—Nausea—Ethinyl Estradiol—prostate cancer	0.000274	0.00241	CcSEcCtD
Ketamine—ABCB1—urethra—prostate cancer	0.000271	0.00811	CbGeAlD
Ketamine—Bradycardia—Capecitabine—prostate cancer	0.000269	0.00236	CcSEcCtD
Ketamine—Anorexia—Mitoxantrone—prostate cancer	0.000268	0.00235	CcSEcCtD
Ketamine—Diplopia—Epirubicin—prostate cancer	0.000266	0.00234	CcSEcCtD
Ketamine—Hypotension—Mitoxantrone—prostate cancer	0.000262	0.0023	CcSEcCtD
Ketamine—Decreased appetite—Estradiol—prostate cancer	0.000262	0.0023	CcSEcCtD
Ketamine—Pain—Estradiol—prostate cancer	0.000258	0.00226	CcSEcCtD
Ketamine—Convulsion—Etoposide—prostate cancer	0.000248	0.00218	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—prostate cancer	0.000246	0.00216	CcSEcCtD
Ketamine—Decreased appetite—Mitoxantrone—prostate cancer	0.000244	0.00214	CcSEcCtD
Ketamine—Arrhythmia—Docetaxel—prostate cancer	0.000244	0.00214	CcSEcCtD
Ketamine—Vomiting—Goserelin—prostate cancer	0.000242	0.00212	CcSEcCtD
Ketamine—Pain—Mitoxantrone—prostate cancer	0.00024	0.00211	CcSEcCtD
Ketamine—Bradycardia—Prednisone—prostate cancer	0.00024	0.00211	CcSEcCtD
Ketamine—Rash—Goserelin—prostate cancer	0.00024	0.0021	CcSEcCtD
Ketamine—Dermatitis—Goserelin—prostate cancer	0.000239	0.0021	CcSEcCtD
Ketamine—Vomiting—Conjugated Estrogens—prostate cancer	0.000239	0.0021	CcSEcCtD
Ketamine—Erythema—Docetaxel—prostate cancer	0.000238	0.00209	CcSEcCtD
Ketamine—Rash—Conjugated Estrogens—prostate cancer	0.000237	0.00208	CcSEcCtD
Ketamine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000237	0.00208	CcSEcCtD
Ketamine—Arrhythmia—Capecitabine—prostate cancer	0.000236	0.00207	CcSEcCtD
Ketamine—Anaphylactic shock—Etoposide—prostate cancer	0.000233	0.00205	CcSEcCtD
Ketamine—Erythema—Capecitabine—prostate cancer	0.00023	0.00202	CcSEcCtD
Ketamine—Nausea—Goserelin—prostate cancer	0.000226	0.00198	CcSEcCtD
Ketamine—Nausea—Conjugated Estrogens—prostate cancer	0.000224	0.00196	CcSEcCtD
Ketamine—Anorexia—Etoposide—prostate cancer	0.000223	0.00195	CcSEcCtD
Ketamine—PTGS1—lymph node—prostate cancer	0.000218	0.00654	CbGeAlD
Ketamine—Hypotension—Etoposide—prostate cancer	0.000218	0.00192	CcSEcCtD
Ketamine—Vision blurred—Capecitabine—prostate cancer	0.000217	0.0019	CcSEcCtD
Ketamine—Arrhythmia—Prednisone—prostate cancer	0.00021	0.00185	CcSEcCtD
Ketamine—ABCB1—bone marrow—prostate cancer	0.000208	0.00624	CbGeAlD
Ketamine—Convulsion—Docetaxel—prostate cancer	0.000206	0.00181	CcSEcCtD
Ketamine—Erythema—Prednisone—prostate cancer	0.000205	0.0018	CcSEcCtD
Ketamine—Decreased appetite—Etoposide—prostate cancer	0.000203	0.00178	CcSEcCtD
Ketamine—Pain—Etoposide—prostate cancer	0.0002	0.00175	CcSEcCtD
Ketamine—Anaphylactic shock—Docetaxel—prostate cancer	0.000194	0.0017	CcSEcCtD
Ketamine—Vision blurred—Prednisone—prostate cancer	0.000193	0.0017	CcSEcCtD
Ketamine—Vomiting—Estradiol—prostate cancer	0.000192	0.00168	CcSEcCtD
Ketamine—Shock—Docetaxel—prostate cancer	0.000191	0.00168	CcSEcCtD
Ketamine—Rash—Estradiol—prostate cancer	0.00019	0.00167	CcSEcCtD
Ketamine—Dermatitis—Estradiol—prostate cancer	0.00019	0.00167	CcSEcCtD
Ketamine—Bradycardia—Epirubicin—prostate cancer	0.000188	0.00165	CcSEcCtD
Ketamine—Anorexia—Docetaxel—prostate cancer	0.000185	0.00162	CcSEcCtD
Ketamine—Shock—Capecitabine—prostate cancer	0.000185	0.00162	CcSEcCtD
Ketamine—Hypotension—Docetaxel—prostate cancer	0.000181	0.00159	CcSEcCtD
Ketamine—Anorexia—Capecitabine—prostate cancer	0.000179	0.00157	CcSEcCtD
Ketamine—Nausea—Estradiol—prostate cancer	0.000179	0.00157	CcSEcCtD
Ketamine—Vomiting—Mitoxantrone—prostate cancer	0.000178	0.00157	CcSEcCtD
Ketamine—ABCB1—testis—prostate cancer	0.000178	0.00534	CbGeAlD
Ketamine—Convulsion—Prednisone—prostate cancer	0.000178	0.00156	CcSEcCtD
Ketamine—Rash—Mitoxantrone—prostate cancer	0.000177	0.00155	CcSEcCtD
Ketamine—Dermatitis—Mitoxantrone—prostate cancer	0.000177	0.00155	CcSEcCtD
Ketamine—Hypotension—Capecitabine—prostate cancer	0.000176	0.00154	CcSEcCtD
Ketamine—Bradycardia—Doxorubicin—prostate cancer	0.000174	0.00152	CcSEcCtD
Ketamine—Decreased appetite—Docetaxel—prostate cancer	0.000169	0.00148	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisone—prostate cancer	0.000167	0.00147	CcSEcCtD
Ketamine—Nausea—Mitoxantrone—prostate cancer	0.000167	0.00146	CcSEcCtD
Ketamine—Pain—Docetaxel—prostate cancer	0.000166	0.00146	CcSEcCtD
Ketamine—Shock—Prednisone—prostate cancer	0.000165	0.00145	CcSEcCtD
Ketamine—Arrhythmia—Epirubicin—prostate cancer	0.000165	0.00144	CcSEcCtD
Ketamine—Decreased appetite—Capecitabine—prostate cancer	0.000163	0.00143	CcSEcCtD
Ketamine—Pain—Capecitabine—prostate cancer	0.000161	0.00141	CcSEcCtD
Ketamine—Erythema—Epirubicin—prostate cancer	0.00016	0.00141	CcSEcCtD
Ketamine—Anorexia—Prednisone—prostate cancer	0.00016	0.0014	CcSEcCtD
Ketamine—Arrhythmia—Doxorubicin—prostate cancer	0.000152	0.00134	CcSEcCtD
Ketamine—Vision blurred—Epirubicin—prostate cancer	0.000151	0.00133	CcSEcCtD
Ketamine—Vomiting—Etoposide—prostate cancer	0.000148	0.0013	CcSEcCtD
Ketamine—Erythema—Doxorubicin—prostate cancer	0.000148	0.0013	CcSEcCtD
Ketamine—Rash—Etoposide—prostate cancer	0.000147	0.00129	CcSEcCtD
Ketamine—Dermatitis—Etoposide—prostate cancer	0.000147	0.00129	CcSEcCtD
Ketamine—Decreased appetite—Prednisone—prostate cancer	0.000145	0.00128	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—prostate cancer	0.00014	0.00123	CcSEcCtD
Ketamine—Convulsion—Epirubicin—prostate cancer	0.000139	0.00122	CcSEcCtD
Ketamine—Nausea—Etoposide—prostate cancer	0.000139	0.00122	CcSEcCtD
Ketamine—Anaphylactic shock—Epirubicin—prostate cancer	0.000131	0.00115	CcSEcCtD
Ketamine—ABCB1—lymph node—prostate cancer	0.000129	0.00387	CbGeAlD
Ketamine—Shock—Epirubicin—prostate cancer	0.000129	0.00113	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—prostate cancer	0.000129	0.00113	CcSEcCtD
Ketamine—Anorexia—Epirubicin—prostate cancer	0.000125	0.0011	CcSEcCtD
Ketamine—Vomiting—Docetaxel—prostate cancer	0.000123	0.00108	CcSEcCtD
Ketamine—Rash—Docetaxel—prostate cancer	0.000122	0.00107	CcSEcCtD
Ketamine—Hypotension—Epirubicin—prostate cancer	0.000122	0.00107	CcSEcCtD
Ketamine—Dermatitis—Docetaxel—prostate cancer	0.000122	0.00107	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000121	0.00106	CcSEcCtD
Ketamine—Vomiting—Capecitabine—prostate cancer	0.000119	0.00105	CcSEcCtD
Ketamine—Shock—Doxorubicin—prostate cancer	0.000119	0.00105	CcSEcCtD
Ketamine—Rash—Capecitabine—prostate cancer	0.000118	0.00104	CcSEcCtD
Ketamine—Dermatitis—Capecitabine—prostate cancer	0.000118	0.00104	CcSEcCtD
Ketamine—Anorexia—Doxorubicin—prostate cancer	0.000115	0.00101	CcSEcCtD
Ketamine—Nausea—Docetaxel—prostate cancer	0.000115	0.00101	CcSEcCtD
Ketamine—Decreased appetite—Epirubicin—prostate cancer	0.000114	0.000999	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—prostate cancer	0.000113	0.000993	CcSEcCtD
Ketamine—Pain—Epirubicin—prostate cancer	0.000112	0.000983	CcSEcCtD
Ketamine—Nausea—Capecitabine—prostate cancer	0.000112	0.00098	CcSEcCtD
Ketamine—Vomiting—Prednisone—prostate cancer	0.000106	0.000934	CcSEcCtD
Ketamine—Rash—Prednisone—prostate cancer	0.000106	0.000926	CcSEcCtD
Ketamine—Dermatitis—Prednisone—prostate cancer	0.000105	0.000925	CcSEcCtD
Ketamine—Decreased appetite—Doxorubicin—prostate cancer	0.000105	0.000924	CcSEcCtD
Ketamine—Pain—Doxorubicin—prostate cancer	0.000104	0.000909	CcSEcCtD
Ketamine—Nausea—Prednisone—prostate cancer	9.94e-05	0.000873	CcSEcCtD
Ketamine—Vomiting—Epirubicin—prostate cancer	8.32e-05	0.000731	CcSEcCtD
Ketamine—Rash—Epirubicin—prostate cancer	8.25e-05	0.000724	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—prostate cancer	8.24e-05	0.000724	CcSEcCtD
Ketamine—Nausea—Epirubicin—prostate cancer	7.77e-05	0.000682	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—prostate cancer	7.7e-05	0.000676	CcSEcCtD
Ketamine—Rash—Doxorubicin—prostate cancer	7.64e-05	0.00067	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—prostate cancer	7.63e-05	0.00067	CcSEcCtD
Ketamine—Nausea—Doxorubicin—prostate cancer	7.19e-05	0.000631	CcSEcCtD
Ketamine—DRD2—Signaling Pathways—HIF1A—prostate cancer	3.03e-06	1.84e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—RXRA—prostate cancer	3.02e-06	1.84e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GGT1—prostate cancer	3.02e-06	1.83e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EP300—prostate cancer	3e-06	1.83e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—LPL—prostate cancer	3e-06	1.83e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	3e-06	1.82e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGF2—prostate cancer	2.97e-06	1.8e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	2.97e-06	1.8e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.96e-06	1.8e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LEP—prostate cancer	2.96e-06	1.8e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAV1—prostate cancer	2.94e-06	1.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—prostate cancer	2.94e-06	1.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—prostate cancer	2.94e-06	1.79e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CAV1—prostate cancer	2.93e-06	1.78e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.93e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOS3—prostate cancer	2.93e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SRC—prostate cancer	2.92e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—prostate cancer	2.92e-06	1.78e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NOS3—prostate cancer	2.92e-06	1.77e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MED12—prostate cancer	2.91e-06	1.77e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—COMT—prostate cancer	2.91e-06	1.77e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—prostate cancer	2.9e-06	1.76e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—prostate cancer	2.9e-06	1.76e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.9e-06	1.76e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNG5—prostate cancer	2.89e-06	1.76e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ERCC2—prostate cancer	2.88e-06	1.75e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—prostate cancer	2.86e-06	1.74e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ITPR1—prostate cancer	2.85e-06	1.73e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—prostate cancer	2.85e-06	1.73e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JAK2—prostate cancer	2.84e-06	1.73e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	2.83e-06	1.72e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ESR1—prostate cancer	2.83e-06	1.72e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—RXRA—prostate cancer	2.82e-06	1.72e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—prostate cancer	2.82e-06	1.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	2.79e-06	1.7e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOA3—prostate cancer	2.78e-06	1.69e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—prostate cancer	2.78e-06	1.69e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—prostate cancer	2.78e-06	1.69e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	2.77e-06	1.68e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—prostate cancer	2.76e-06	1.68e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BAD—prostate cancer	2.76e-06	1.68e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.75e-06	1.67e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—prostate cancer	2.74e-06	1.66e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—COMT—prostate cancer	2.72e-06	1.65e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—prostate cancer	2.71e-06	1.65e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MTHFR—prostate cancer	2.7e-06	1.64e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	2.7e-06	1.64e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TYMS—prostate cancer	2.7e-06	1.64e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—prostate cancer	2.69e-06	1.64e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CB—prostate cancer	2.69e-06	1.64e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.68e-06	1.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—prostate cancer	2.67e-06	1.62e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CG—prostate cancer	2.67e-06	1.62e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—prostate cancer	2.67e-06	1.62e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ITPR1—prostate cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—prostate cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARA—prostate cancer	2.65e-06	1.61e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IRS1—prostate cancer	2.64e-06	1.61e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGF—prostate cancer	2.64e-06	1.61e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.64e-06	1.61e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EP300—prostate cancer	2.63e-06	1.6e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.62e-06	1.59e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—prostate cancer	2.62e-06	1.59e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—LPL—prostate cancer	2.61e-06	1.59e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—prostate cancer	2.61e-06	1.59e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—prostate cancer	2.6e-06	1.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.58e-06	1.57e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ACHE—prostate cancer	2.58e-06	1.57e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GSK3B—prostate cancer	2.56e-06	1.56e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SRC—prostate cancer	2.56e-06	1.56e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—prostate cancer	2.56e-06	1.56e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.55e-06	1.55e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—INS—prostate cancer	2.54e-06	1.54e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	2.54e-06	1.54e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—INS—prostate cancer	2.53e-06	1.54e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP1A1—prostate cancer	2.53e-06	1.54e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TYMS—prostate cancer	2.52e-06	1.53e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	2.51e-06	1.53e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ERCC2—prostate cancer	2.5e-06	1.52e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—prostate cancer	2.5e-06	1.52e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAV1—prostate cancer	2.49e-06	1.52e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—prostate cancer	2.49e-06	1.51e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CREBBP—prostate cancer	2.49e-06	1.51e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—prostate cancer	2.48e-06	1.51e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—prostate cancer	2.48e-06	1.51e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.48e-06	1.51e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CREBBP—prostate cancer	2.48e-06	1.51e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—prostate cancer	2.47e-06	1.5e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—prostate cancer	2.47e-06	1.5e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.46e-06	1.5e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—prostate cancer	2.45e-06	1.49e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—LPL—prostate cancer	2.44e-06	1.49e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.44e-06	1.48e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—prostate cancer	2.43e-06	1.48e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—prostate cancer	2.42e-06	1.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—prostate cancer	2.42e-06	1.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	2.4e-06	1.46e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.38e-06	1.45e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAP2K1—prostate cancer	2.36e-06	1.44e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.36e-06	1.43e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.36e-06	1.43e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MTHFR—prostate cancer	2.35e-06	1.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CD—prostate cancer	2.35e-06	1.43e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—prostate cancer	2.35e-06	1.43e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ERCC2—prostate cancer	2.34e-06	1.42e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	2.34e-06	1.42e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—prostate cancer	2.33e-06	1.42e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—prostate cancer	2.33e-06	1.42e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	2.33e-06	1.41e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.32e-06	1.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SERPINE1—prostate cancer	2.32e-06	1.41e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARA—prostate cancer	2.31e-06	1.4e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—prostate cancer	2.3e-06	1.4e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—prostate cancer	2.3e-06	1.4e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—prostate cancer	2.29e-06	1.39e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—prostate cancer	2.28e-06	1.38e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.27e-06	1.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGF2—prostate cancer	2.25e-06	1.37e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—prostate cancer	2.25e-06	1.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EP300—prostate cancer	2.23e-06	1.35e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NOS3—prostate cancer	2.23e-06	1.35e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	2.22e-06	1.35e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—EP300—prostate cancer	2.22e-06	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOS3—prostate cancer	2.22e-06	1.35e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.22e-06	1.35e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MTHFR—prostate cancer	2.2e-06	1.34e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAV1—prostate cancer	2.17e-06	1.32e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.17e-06	1.32e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SRC—prostate cancer	2.17e-06	1.32e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARA—prostate cancer	2.16e-06	1.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JAK2—prostate cancer	2.16e-06	1.31e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—prostate cancer	2.15e-06	1.31e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—INS—prostate cancer	2.15e-06	1.31e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NQO1—prostate cancer	2.14e-06	1.3e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—prostate cancer	2.12e-06	1.29e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	2.11e-06	1.28e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TH—prostate cancer	2.11e-06	1.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—prostate cancer	2.11e-06	1.28e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CREBBP—prostate cancer	2.11e-06	1.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—prostate cancer	2.1e-06	1.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—prostate cancer	2.09e-06	1.27e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—prostate cancer	2.07e-06	1.26e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CB—prostate cancer	2.06e-06	1.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.05e-06	1.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	2.05e-06	1.25e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—prostate cancer	2.04e-06	1.24e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAV1—prostate cancer	2.03e-06	1.23e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CD—prostate cancer	2e-06	1.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GGT1—prostate cancer	1.99e-06	1.21e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.98e-06	1.2e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—prostate cancer	1.97e-06	1.2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.97e-06	1.2e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.96e-06	1.19e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	1.95e-06	1.18e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—prostate cancer	1.94e-06	1.18e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.94e-06	1.18e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—prostate cancer	1.94e-06	1.18e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.93e-06	1.17e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.92e-06	1.17e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.9e-06	1.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—prostate cancer	1.9e-06	1.15e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—prostate cancer	1.89e-06	1.15e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NOS3—prostate cancer	1.88e-06	1.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—prostate cancer	1.88e-06	1.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—prostate cancer	1.88e-06	1.14e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—INS—prostate cancer	1.87e-06	1.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—prostate cancer	1.87e-06	1.14e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—RXRA—prostate cancer	1.86e-06	1.13e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.85e-06	1.12e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CREBBP—prostate cancer	1.83e-06	1.12e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—prostate cancer	1.83e-06	1.11e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—prostate cancer	1.82e-06	1.1e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.82e-06	1.1e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—COMT—prostate cancer	1.79e-06	1.09e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—prostate cancer	1.79e-06	1.09e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.79e-06	1.09e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—prostate cancer	1.78e-06	1.08e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—prostate cancer	1.78e-06	1.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.77e-06	1.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—prostate cancer	1.77e-06	1.08e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.76e-06	1.07e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—INS—prostate cancer	1.75e-06	1.06e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.74e-06	1.06e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.74e-06	1.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.73e-06	1.05e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—prostate cancer	1.73e-06	1.05e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.72e-06	1.05e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.71e-06	1.04e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—EP300—prostate cancer	1.69e-06	1.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EP300—prostate cancer	1.69e-06	1.03e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TYMS—prostate cancer	1.66e-06	1.01e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	1.65e-06	1e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NOS3—prostate cancer	1.64e-06	9.99e-06	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—prostate cancer	1.64e-06	9.98e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.64e-06	9.98e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SRC—prostate cancer	1.64e-06	9.98e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.62e-06	9.88e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LPL—prostate cancer	1.61e-06	9.8e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.6e-06	9.72e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—prostate cancer	1.59e-06	9.69e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—prostate cancer	1.59e-06	9.68e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.58e-06	9.62e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.56e-06	9.46e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.54e-06	9.38e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NOS3—prostate cancer	1.53e-06	9.33e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.52e-06	9.22e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—prostate cancer	1.5e-06	9.14e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—prostate cancer	1.5e-06	9.13e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—prostate cancer	1.47e-06	8.94e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.47e-06	8.92e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—prostate cancer	1.46e-06	8.87e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.45e-06	8.82e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.44e-06	8.74e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—EP300—prostate cancer	1.43e-06	8.72e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARA—prostate cancer	1.42e-06	8.65e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.42e-06	8.61e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.4e-06	8.53e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—prostate cancer	1.36e-06	8.26e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.35e-06	8.18e-06	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—prostate cancer	1.34e-06	8.16e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAV1—prostate cancer	1.34e-06	8.14e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—prostate cancer	1.31e-06	7.96e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.25e-06	7.62e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—EP300—prostate cancer	1.25e-06	7.6e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.25e-06	7.59e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—prostate cancer	1.22e-06	7.44e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.22e-06	7.41e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—prostate cancer	1.21e-06	7.34e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—EP300—prostate cancer	1.17e-06	7.1e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—INS—prostate cancer	1.15e-06	7.02e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.13e-06	6.87e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—prostate cancer	1.11e-06	6.72e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.07e-06	6.51e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.06e-06	6.45e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—prostate cancer	1.02e-06	6.22e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—prostate cancer	1.02e-06	6.2e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NOS3—prostate cancer	1.01e-06	6.15e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CB—prostate cancer	9.34e-07	5.68e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—prostate cancer	9.25e-07	5.63e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—prostate cancer	9.24e-07	5.62e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—prostate cancer	8.66e-07	5.27e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—prostate cancer	8.63e-07	5.25e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—prostate cancer	8.07e-07	4.91e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—EP300—prostate cancer	7.7e-07	4.68e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—prostate cancer	7.55e-07	4.59e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—prostate cancer	7.05e-07	4.29e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.69e-07	3.46e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—prostate cancer	4.65e-07	2.83e-06	CbGpPWpGaD
